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Antimicrobial agents used for the last few decades have greatly reduced the illness and death from infectious diseases. Antibiotic use is beneficial when prescribed 
and taken correctly; their value in care of the patient is enormous. 
However, these drugs have been used so widely and for so long 
that the infectious organisms have adapted to the antibiotics which 
are designed to kill them, making these drugs less effective. Some 
microorganisms develop resistance to a single antimicrobial agent 
(or related class of agent), while others develop resistance to 
several antimicrobial agents or classes. The microorganisms have 
become so resistant in some cases that no available antibiotics 
are effective against them. In laboratory, an isolate is described 
as resistant to an antimicrobial when it is not inhibited by usual 
concentration of the agent with normal dosage schedule, and/or 
when it demonstrates that the fall in the range where specific 
resistance are likely, and the clinical efficacy of the agent against 
the isolate has not been reliably shown in the treatment studies 
(Clinical and Laboratory Standards Institute [CLSI]) [1].
Development of antimicrobial resistance may occur naturally 
via natural selection through random mutation or by programmed 
evolution. Programmed evolution is a regulated process in which 
the organism switches on altered levels (usually higher) to sensed 
non-mutagenic environmental cues. Three main mechanisms by 
which Gram-negative organisms exhibit resistance to antimicrobials 
are as follows: (1) Hydrolysis of drugs by enzymes, (2) decreased 
permeability of the antibiotic into the cell, and (3) decreased 
affinity of the target [2,3]. In the above mentioned, expression of 
β-lactamases is the major mechanism of resistance causing clinically 
significant infection in Gram-negative organisms [2]. β-lactamases 
are the enzymes capable of hydrolyzing β-lactam ring of penicillin, 
cephalosporin, and related antimicrobial drug rendering them 
inactive. β-lactamases vary in substrate and host range [4]. All 
Enterobacteriaceae produces intrinsic resistance of individual 
species to some antibiotics, except Salmonella species [5].
Recommended antimicrobial agents used in antimicrobial 
susceptibility test on Gram-negative rods include 2nd- and 
3rd-generation cephalosporin, piperacillin, antipseudomonal 
penicillin, fluoroquinolone, trimethoprim-sulfamethoxazole, and 
aminoglycoside. Nitrofurantoin, quinolone, and trimethoprim are 
included in antimicrobial susceptibility test when the organism is 
isolated from pathological specimens [6]. Characteristic feature of 
extended-spectrum beta-lactamase (ESBL)-mediated resistance 
in Enterobacteriaceae is resistance to penicillin as well as to 
2nd-generation and one or more of 3rd-generation and 4th-generation 
cephalosporin or aztreonam. However, transmission electron 
microscopy and (Sulphydryl variable) SHV type of ESBL are 
not able to hydrolyze extended-spectrum β-lactam antibiotics as 
efficiently as their parent enzyme [7].
Another feature of ESBL-mediated resistance is increased 
susceptibility to β-lactamase inhibitor particularly clavulanate [7] 
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due to the expansion of active site of ESBL producer which allows 
its increased activity against the extended-spectrum cephalosporin. 
This characteristic feature makes possible a synergy between 
cephalosporins and β-lactamase inhibitors. Clavulanic acid and 
tazobactam have better inhibitory activity than sulbactam. The 
objective of this study is to identify the antibiogram resistance 
pattern of ESBL-positive bacterial isolates.
MATERIALS AND METHODS
This prospective, observational study was conducted in 
Rajarajeswari Medical College and Hospital, Bangalore, over a 
period of 12 months from February 2015 to January 2016. Sample 
size is determined by equation n≥z2 (pq)/d2 (n=sample size, z=a 
constant 1.96, p=prevalence, q=100−prevalence, d=relative error). 
In India, the prevalence of ESBL infection is highly variable, and 
as per the data available from the Department of Microbiology of 
our college, prevalence was 23.55%. Hence, in this study, p=23.5, 
q=76.5, d=11, and as per the formula, calculated sample size was 60.
All the Gram-negative bacterial isolates from the clinical 
samples such as sputum, pus, urine, ascitic fluid, colony-
stimulating factor, pleural fluid, and miscellaneous samples 
received from the children aged 0-18 years admitted to our 
hospital were included in the study. Children in whom bacterial 
culture grew mixture of organisms or children treated with 
antibiotics before the collection of pathological specimen for 
culture were excluded from the study. Ethical clearance for the 
study was obtained from the Committee on Human Research, 
publication, and ethics of our institution.
Isolation
Samples were collected under aseptic precaution and processed. 
Antimicrobial sensitivity was performed by Kirby-Bauer disk 
diffusion method on Mueller-Hilton agar using commercially 
available antibiotic discs as per CLSI Guidelines-2014. ESBL 
was detected by the combined disc method using ceftazidime and 
clavulanic acid and cefotaxime and cefotaxime-clavulanic acid.
Case was defined as any person <18 years old presenting with 
fever with associated symptoms such as cough, expectoration, 
chest pain, wheeze, and shortness of breath; lower abdominal 
pain, frequency, dysuria, urgency, vomiting, and voiding 
difficulty; vomiting, reduced feeding, lethargy with or without 
fever, with features of shock pointing toward septicemia; or 
ear discharge. Laboratory investigations including complete 
hemogram, urine microscopy, liver function test, renal function 
test, arterial blood gas analysis, erythrocyte sedimentation rate, 
and C-reactive protein were done as per the protocol. A positive 
culture within 48 h of admission was considered as community-
acquired infection, whereas those obtained after this period was 
defined as hospital-acquired infection. Patients were managed 
according to the standard protocols and blood investigations 
were repeated on day 0, day 3, and day 5 and on the day of 
discharge.
Antibiotic therapy including drugs, dosage, duration, and 
frequency was evaluated for each patient. Empirical treatment was 
defined as initial antibiotic regimen used before the organism was 
identified. Definitive therapy was defined as the regimen chosen 
after the isolation of organism and susceptibilities were available. 
Antibiotics were changed according to the clinical response.
Data of 60 patients were considered for analysis. Descriptive 
statistics were applied. Microsoft Excel 2010 and SPSS software 
were used for data analysis. Chi-square and Student’s t-test were 
used to know the association of variables. Significant level was 
fixed at 0.05.
RESULTS
In our study, male:female ratio was 1:1 and there were 10% females 
and 12% males in the age group of 0-28 days as shown in Table 1. 
The most common symptom at the time of presentation was fever 
(27 cases), followed by vomiting (22 cases) and poor feeding 
(21 cases). The frequency distributions of clinical presentation 
of cases according to age group are shown in Table 2. The most 
common used antibiotic for empiric therapy was ceftriaxone 
(20 cases), followed by ampicillin and amoxicillin-clavulanic 
acid (12 cases each) as shown in Table 3.
Escherichia coli (45% cases) were the most common 
ESBL-producing organisms isolated from the study population, 
followed by Klebsiella spp. and Pseudomonas in 18.3% cases 
each. Organisms isolated from different body fluids are shown 
Table 1: Age group – sex distribution
Age group Number of patients Total (%)
Female (%) Male (%)
0-28 days 6 (10) 7 (12) 13 (22)
29 days-1 year 9 (15) 8 (13) 17 (28)
>1-6 years 7 (12) 4 (7) 11 (19)
>6-18 years 8 (13) 11 (18) 19 (31)
Total 30 (50) 30 (50) 60 (100)
Table 2: Distribution of clinical presentation according to age group
Age group Fever Dysuria Loose stools Constipation Voiding 
difficulty
Vomiting Pain 
abdomen
Cough Reduced 
feeding
0-28 days 2 1 Nil Nil Nil 4 Nil Nil 12
29 days-1 year 4 2 5 Nil 1 8 1 6 4
>1 year-6 years 10 2 2 1 3 2 4 2 3
>6 years-18 years 11 3 Nil 3 Nil 8 7 5 2
Grand total 27 8 7 4 4 22 12 13 21
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in Table 4, and their sensitivity to different antibiotics is shown 
in Table 5.
In our study, antibiotics were given for following duration 
depending upon the clinical diagnosis and severity of infection: 
Culture positive urinary tract infection (UTI) was treated for 
14 days, septicemia for 10 days, bacillary dysentery for 7 days, 
and others such as acute suppurative otitis media/chronic 
suppurative otitis media for 5 days. In pneumonia, of 12 patients, 
11 were treated for 10 days while 1 was treated for 14 days due to 
associated acute respiratory distress syndrome (day 6).
DISCUSSION
The minimum number of patients (18.3%) belonged to the 
age between >1-6 years, and the maximum number of patients 
belonged to the age of >6-18 years (31.7% cases). There was 
equal incidence of infection with ESBL-producing organisms in 
both the sex. However, the study conducted by Sehgal et al. [8] 
showed male preponderance and premature babies as a major 
risk. Another study conducted by Patel et al. [9] showed female 
preponderance and age group of >1-5 years as the common age 
group affected.
E. coli was the most common ESBL-producing organism 
isolated from the study population which accounted for 45%. 
Table 5: Antibiotic sensitivity pattern of different organisms isolated in culture specimen
Antibiotics E. coli  
(n=27)
Klebsiella 
pneumoniae 
(n=5)
Klebsiella 
oxytoca  
(n=6)
Pseudomonas 
aeruginosa  
(n=11)
Proteus 
mirabilis  
(n=4)
Enterobacter 
species  
(n=3)
Acinetobacter 
lowfii  
(n=2)
Acinetobacter 
bowmonii  
(n=1)
Moraxella 
(n=1)
Amikacin 25 3 4 9 3 3 2 1 1
Ampicillin 6 1 1 2 1 - - - -
Cefotaxime 5 2 1 3 1 - - - -
Cefuroxime 4 2 1 1 1 - - - -
Imipenem 26 4 4 8 4 2 1 - 1
Nitrofurantoin 23 2 2 6 3 2 1 - 1
Piperacillin/tazobactam 24 4 4 7 2 2 2 1 -
Cephalexin 5 1 1 3 1 - - - -
Amoxicillin/clavulanic 
acid
3 1 2 2 1 - - - -
Aztreonam 9 2 2 5 2 1 1 - -
Ceftazidime 7 2 1 2 1 - - - -
Ciprofloxacin 6 1 1 2 1 - - - -
Meropenem 24 5 4 9 4 3 2 1 1
Norfloxacin 19 2 3 7 3 2 1 - -
Trimethoprim/
sulfamethoxazole
18 3 4 7 3 2 1 1 1
E. coli: Escherichia coli
Table 4: Organisms isolated in the culture samples
Culture 
sample
Organism isolated Total (%)
E. coli (%) Klebsiella 
species (%)
Pseudomonas 
aeruginosa (%)
Proteus 
species (%)
Enterobacter 
species (%)
Acinetobacter 
species (%)
Moraxella 
species (%)
Urine 16 (26.7) 1 (1.7) 0 4 (6.7) 0 0 0 21 (35)
Blood 6 (10) 4 (6.7) 0 0 2 (3.3) 1 (1.7) 0 13 (21.7)
ET secretion 2 (3.3) 0 8 (13.3) 0 1 (1.7) 0 1 (1.7) 12 (20)
Sputum 1 (1.7) 6 (10) 0 0 0 0 0 7 (11.7)
Pus 0 0 2 (3.3) 0 0 2 (3.3) 0 4 (6.7)
Stool 2 (3.3) 0 0 0 0 0 0 2 (3.3)
PICC line tip 0 0 1 (1.7) 0 0 0 0 1 (1.7)
Total 27 (45) 11 (18.3) 11 (18.3) 4 (6.7) 3 (5) 3 (5) 1 (1.7) 60 (100)
E. coli: Escherichia coli, PICC: Peripherally inserted central catheters
Table 3: Empirical antibiotics used in the study is shown in the 
following table
Empirical antibiotics Frequency (%)
Ampicillin 12 (20.0)
Ceftriaxone 20 (33.3)
Co-amoxiclav 12 (20.0)
Amikacin 4 (6.7)
Cefotaxime 3 (5.0)
Piperacillin/tazobactam 8 (13.3)
Meropenem 1 (1.7)
Total 60 (100.0)
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The next common organisms were Klebsiella species and 
Pseudomonas accounting to 18.3% each. However, according 
to study conducted by Patel et al. [9], the most common isolate 
was E. coli (58.9%) followed by Klebsiella species (16.1%) 
and Enterococcus species (10.7%). Tumbrels et al shows that 
majority of infections caused urinary tract infections and lower 
tract infections [10].
Ceftriaxone was the most commonly used empirical antibiotic 
in our study group which accounted for 33.3%. This is according 
to an update by Paterson and Bonobo [9] due to the high rates 
of UTI in the study group. However, on the contrary to their 
recommendations [11] to start carbapenem as the 1st-line drug for 
ESBL infections other than UTI, piperacillin/tazobactam (47.3%) 
and meropenem (27%) were used as per the culture and sensitivity 
reports in our study population. Only 23% of the study population 
was subjected to therapy with amikacin, which was initiated in 
case of deterioration with the use of other antibiotic regimen. 
Majority of the patients had therapy for 6-10 weeks, which was 
reported to be nearly 58% of the total study population and 81.7% 
had to use 2 antibiotics. However, mean duration of antibiotic 
therapy was 12.5 days in study conducted by Sehgal et al. [8].
In our study, duration of antibiotics was based on clinical 
diagnosis and severity of infection as shown in Table 6.
In our study, 18% died and 82% got discharged in patients 
where no change of empirical antibiotic was done, while 6% 
died and 94% got discharged in those patients where change in 
empirical antibiotic was done as shown in Table 7. According 
to a study conducted by Sehgal et al. [8], mortality rate was 
23.6%. The association of change in antibiotic to mortality was 
found to have significance. The change in antibiotic in cases of 
deterioration of the illness showed a non-significant decrease in 
mortality (p=0.191). Hence, it is recommended to change the 
antibiotics for getting better outcome.
CONCLUSION
The most common ESBL-producing organism isolated from the 
study population was E. coli followed by Klebsiella species and 
Pseudomonas. The most commonly used empirical antibiotic in 
our study group was ceftriaxone. Piperacillin/tazobactam and 
meropenem were used as per the culture and sensitivity reports. 
In case of deterioration with the use of other antibiotic regimen, 
amikacin was initiated.
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Table 6: Duration of antibiotic depending upon clinical diagnosis
Clinical 
diagnosis
Average days of antibiotic given Total
0-5 days 6-10 days 11-14 days
UTI 0 0 20 (33.3%) 20 (33.3%)
Septicemia 0 21 (35%) 0 21 (35%)
Pneumonia 0 11 (18.3%) 1 (1.7%) 12 (20%)
Bacillary 
dysentery
0 3 (5%) 0 3 (5%)
Others 4 (6.7%) 0 0 4 (6.7%)
Total 4 (6.7%) 35 (58.3%) 21 (35%) 60 (100%)
UTI: Urinary tract infection
Table 7: Comparison between change in empirical antibiotic and 
outcome
Change in empirical 
antibiotic
Outcome Total
Frequency (%)
Death Discharged
No 2 (18) 9 (82) 11
Yes 3 (6) 46 (94) 49
Total 5 (8) 55 (92) 60
Pearson Chi-square 1.710
p value 0.191 not significant
Funding: None; Conflict of Interest: None Stated.
How to cite this article: Manjunath BS, Adarsh E, Rajanish KV, Trupthi S, 
Niveditha C, Raj  DK. Antibiogram resistance pattern of extended-spectrum 
beta-lactamase-positive bacterial isolates. Indian J Child Health. 2017; 
4(3):341-344.
